Immunocore Holdings (IMCR) Change in Acquisitions & Divestments (2025 - 2026)

Immunocore Holdings' (IMCR) quarterly Change in Acquisitions & Divestments came in at $6.0 million in Q1 2026, down 40.0% year-on-year from $10.0 million in Q1 2025, and up 200.0% quarter-over-quarter from $2.0 million in Q4 2025.

Immunocore Holdings (IMCR) Change in Acquisitions & Divestments (2025 - 2026) Analysis & Trends

Immunocore Holdings has disclosed Change in Acquisitions & Divestments across 2 years of filings, most recently posting $6.0 million for Q1 2026.

  • Change in Acquisitions & Divestments for Q1 2026 came in at $6.0 million, down 40.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.0 million (up 40.0% YoY), and the FY2025 annual result was $18.0 million, changed N/A from the prior year.
  • Change in Acquisitions & Divestments came in at $6.0 million for Q1 2026 at Immunocore Holdings, up from $2.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $10.0 million in Q1 2025 to a low of $2.0 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn -
2 Belite Bio 55,234.00 Bn 55,234.00 Bn -
3 Quantum Biopharma 17,823.14 Bn 17,823.14 Bn -
4 Legend Biotech 3,624.50 Bn 3,624.21 Bn 242.10 Mn
5 Akari Therapeutics 1,745.73 Bn 1,745.73 Bn -
6 Evaxion A 1,540.85 Bn 1,540.84 Bn -
7 Psyence Biomedical 229.39 Bn 229.38 Bn -
8 Vertex Pharmaceuticals 112.57 Bn 105.33 Bn 2.59 Bn
9 Abivax 93.46 Bn 93.46 Bn -
10 Immunocore Holdings 1.46 Bn 616.35 Mn 106.24 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.00 Mn
Mar 31, 2026 6.00 Mn
Dec 31, 2025 2.00 Mn
Dec 31, 2025 2.00 Mn
Sep 30, 2025 6.00 Mn
Sep 30, 2025 6.00 Mn
Mar 31, 2025 10.00 Mn
Mar 31, 2025 10.00 Mn